Development of a Bacillus subtilis-based rotavirus vaccine - Wikidata - awgldk - TriplyDB

Development of a Bacillus subtilis-based rotavirus vaccine

Development of a Bacillus subtilis-based rotavirus vaccine

http://www.wikidata.org/entity/Q34289936

about

Probiotics, prebiotics, and the host microbiome: the science of translation Roadblock repression of transcription by Bacillus subtilis CodY.Phages bearing affinity peptides to bovine rotavirus differentiate the virus from other viruses.Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.Mucosal adjuvant activity of IL-2 presenting spores of bacillus subtilis in a murine model of Helicobacter pylori vaccination.Recombinant Bacillus subtilis Spores Elicit Th1/Th17-Polarized Immune Response in a Murine Model of Helicobacter pylori Vaccination.Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.Bacillus amyloliquefaciens SQR9 induces dendritic cell maturation and enhances the immune response against inactivated avian influenza virus.Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.Comparative analysis of Bacillus subtilis spores and monophosphoryl lipid A as adjuvants of protein-based mycobacterium tuberculosis-based vaccines: partial requirement for interleukin-17a for induction of protective immunity.The combination of recombinant and non-recombinant Bacillus subtilis spore display technology for presentation of antigen and adjuvant on single spore.Protective immunity against Eimeria tenella infection in chickens following oral immunization with Bacillus subtilis expressing Eimeria tenella 3-1E protein.TLR sensing of bacterial spore-associated RNA triggers host immune responses with detrimental effects.Biological Containment of Genetically Modified Bacillus subtilis.The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT IL-1 Fragment Modulates Immune Response Elicited by Recombinant Bacillus subtilis Spores Presenting an Antigen/Adjuvant Chimeric Protein

P2860

Q28657826-F7453522-E997-4EA6-BD2E-A49863E98111 Q29346700-B65AD1CD-D732-4294-8748-D4A3DACC0DA6 Q34097975-BE905B78-60B7-434F-BB16-55466F3AEF32 Q34291161-335D701C-E2D6-484B-AF13-F119E102349E Q35066293-BBC057C3-02A5-4D24-B85B-B36217CA42C3 Q35152187-2B9AA697-CB19-4752-82FA-E9913A9831CB Q35856089-06B6D366-C1D3-4645-8AA1-FE4242023661 Q36391905-98C1776A-7F01-487F-BBF8-23691D72E0BF Q36595528-2BAAFD79-3B3F-4F68-94DD-88A08455CBBD Q37530403-8B9FF6CD-9262-48B2-8628-CF316345A5C4 Q37712810-D2085012-4719-40F5-B17A-A4124FF37AAA Q40050837-DAF349DE-84AF-4B38-8D9D-6D7277E68F29 Q41212875-EDD845C7-9E66-498C-8EEB-BE95103E7200 Q43097078-B7B6CE35-753B-4617-89AE-77E82EE10ED0 Q46259284-462CEF9E-7EF4-49AF-AAFA-7D7BCAAE4816 Q57945015-2E296A9C-1D66-4016-9FCE-714CC3BCB0B6 Q58766070-6DC23C7E-A64B-4D38-A06C-91E7FCF5328A

P2860

Development of a Bacillus subtilis-based rotavirus vaccine

http://www.wikidata.org/entity/Q34289936

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Development of a Bacillus subtilis-based rotavirus vaccine

@ast

Development of a Bacillus subtilis-based rotavirus vaccine

@en

Development of a Bacillus subtilis-based rotavirus vaccine

@nl

type

label

Development of a Bacillus subtilis-based rotavirus vaccine

@ast

Development of a Bacillus subtilis-based rotavirus vaccine

@en

Development of a Bacillus subtilis-based rotavirus vaccine

@nl

prefLabel

Development of a Bacillus subtilis-based rotavirus vaccine

@ast

Development of a Bacillus subtilis-based rotavirus vaccine

@en

Development of a Bacillus subtilis-based rotavirus vaccine

@nl

P1433

Q34289936-6F9EB8AD-8A5B-48C7-BE43-BCBAA8637960

P1476

Q34289936-AFBF8537-0DC5-4B16-8754-30F14EAEB3C4

P2093

Q34289936-049FFBFE-C51F-47A5-8211-2E8FB6D8188F

Q34289936-167433D4-B595-4C32-AB47-581F59978C82

Q34289936-30BA39A9-9E1D-41E0-AF11-F40C9F0DD310

Q34289936-34807F51-6334-4D73-BE53-9CD3C499E0F8

Q34289936-4B7D5666-04CA-4BBC-9170-BA4517002B11

Q34289936-8DD4DE06-758C-4FE9-8C10-02153AA5C5F0

Q34289936-CE1FB94D-DE03-47DC-BF0D-3E52FAB8192D

Q34289936-DF87F627-F32C-4D81-AA06-818CB0468A43

Q34289936-F98260E9-C6B7-45CF-916D-13476527625E

P2860

Q34289936-05F5A1F7-C2B0-403F-9A15-355C7D41D92B

Q34289936-0CE77028-A7CA-4FA3-9557-6428C606F675

Q34289936-10EF28D1-C50A-4600-AC71-34F65A0A5DAF

Q34289936-248585E9-7C69-4FE2-A7E6-31D68B8F1456

Q34289936-2F0D5DAB-645A-42FF-999A-C04780C104D5

Q34289936-37B16CC4-E85D-47AD-960F-E9EA86C1AED0

Q34289936-3F576BF8-C588-4538-BBB0-F086D26EAE71

Q34289936-41286C65-C547-48E2-9D81-1B193B73F021

Q34289936-4510B551-344F-43D1-8F97-8EACA2C3736A

Q34289936-4C14E9C9-58F9-4699-9E02-9A0E7C91950C

P304

Q34289936-6038B588-927D-486B-B034-912D42AD8261

P31

Q34289936-02E7E846-7282-4E7D-926C-65501EB6562E

P356

Q34289936-202EDADB-F3B4-43F1-9D54-CDE8E49EDE7F

P433

Q34289936-46F2BC6B-00AC-499F-AB2B-6EE67CB10D39

P478

Q34289936-3D4807CF-54B3-4D31-8662-E2E8AADF288E

P50

Q34289936-74222BE8-D345-447D-A1A2-747F574C0C33

P577

Q34289936-44D653B3-DA07-4AE6-905D-C42458C42A54

P698

Q34289936-6FCD555E-985E-4B86-8E22-FC1A15119808

P932

Q34289936-A2E8B963-1712-44A5-A15D-D6BFF60C09A3

P356

P1433

Clinical and Vaccine Immunology

P1476

Development of a Bacillus subtilis-based rotavirus vaccine

@en

P2093

Abraham L Sonenshein

http://www.w3.org/2001/XMLSchema#string

Boris R Belitsky

http://www.w3.org/2001/XMLSchema#string

David W Brown

http://www.w3.org/2001/XMLSchema#string

Gerald T Keusch

http://www.w3.org/2001/XMLSchema#string

James P Brinker

http://www.w3.org/2001/XMLSchema#string

John D Clements

http://www.w3.org/2001/XMLSchema#string

John E Herrmann

http://www.w3.org/2001/XMLSchema#string

Kathryn O Kerstein

http://www.w3.org/2001/XMLSchema#string

Sangun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments

Rotavirus vaccines: an overview

Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors

Role and regulation of Bacillus subtilis glutamate dehydrogenase genes

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus.

Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.

Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.

P304

1647-1655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00135-10

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20810679

http://www.w3.org/2001/XMLSchema#string

P932

2976104

http://www.w3.org/2001/XMLSchema#string